Stifel Financial Corp Increases Position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Stifel Financial Corp lifted its holdings in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 33.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 40,790 shares of the company’s stock after buying an additional 10,224 shares during the period. Stifel Financial Corp owned approximately 0.06% of Bioceres Crop Solutions worth $321,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in BIOX. Dimensional Fund Advisors LP boosted its stake in shares of Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after buying an additional 5,341 shares in the last quarter. Ping Capital Management Inc. purchased a new stake in shares of Bioceres Crop Solutions during the 2nd quarter worth $448,000. Long Focus Capital Management LLC increased its holdings in shares of Bioceres Crop Solutions by 19.9% in the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock valued at $3,145,000 after purchasing an additional 46,647 shares in the last quarter. Finally, Fourth Sail Capital LP lifted its stake in shares of Bioceres Crop Solutions by 20.5% in the second quarter. Fourth Sail Capital LP now owns 1,961,825 shares of the company’s stock valued at $21,992,000 after purchasing an additional 334,195 shares during the period. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ BIOX opened at $6.35 on Friday. The stock has a market capitalization of $399.08 million, a P/E ratio of 317.66 and a beta of 0.51. Bioceres Crop Solutions Corp. has a 52-week low of $5.71 and a 52-week high of $14.05. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.37. The firm’s 50-day moving average price is $6.65 and its two-hundred day moving average price is $8.71.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The business had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. During the same quarter last year, the firm posted ($0.07) EPS. As a group, sell-side analysts forecast that Bioceres Crop Solutions Corp. will post 0.12 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Roth Mkm cut their price target on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Oppenheimer reduced their price target on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, October 21st. Lake Street Capital dropped their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Finally, Canaccord Genuity Group reduced their target price on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Four analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, Bioceres Crop Solutions has a consensus rating of “Buy” and an average target price of $12.13.

Bioceres Crop Solutions Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.